Metabolomic analysis reveals altered skeletal muscle amino acid and fatty acid handling in obese humans.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 25864501)

Published in Obesity (Silver Spring) on April 10, 2015

Authors

Peter R Baker1,2, Kristen E Boyle1,3, Timothy R Koves4,5, Olga R Ilkayeva4,5, Deborah M Muoio4,5, Joseph A Houmard6, Jacob E Friedman1,7

Author Affiliations

1: Department of Pediatrics, University of Colorado Denver School of Medicine, Aurora, Colorado, USA.
2: Sections of Clinical Genetics and Metabolism, University of Colorado Denver School of Medicine, Aurora, Colorado, USA.
3: Nutrition, University of Colorado Denver School of Medicine, Aurora, Colorado, USA.
4: Department of Pharmacology, Stedman Center for Nutrition, Duke University School of Medicine, Durham, North Carolina, USA.
5: Duke Molecular Physiology Institute, Duke University Medical Center, Durham, North Carolina, USA.
6: Department of Kinesiology, East Carolina University, Greenville, North Carolina, USA.
7: Neonatology, University of Colorado Denver School of Medicine, Aurora, Colorado, USA.

Articles cited by this

Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia (1985) 109.13

Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA (2014) 36.94

Annual medical spending attributable to obesity: payer-and service-specific estimates. Health Aff (Millwood) (2009) 12.45

Metabolite profiles and the risk of developing diabetes. Nat Med (2011) 12.22

A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab (2009) 11.46

Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab (2008) 9.74

Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J Clin Invest (2009) 5.66

A Biometric Study of Human Basal Metabolism. Proc Natl Acad Sci U S A (1918) 4.74

The key role of anaplerosis and cataplerosis for citric acid cycle function. J Biol Chem (2002) 4.20

Elevated stearoyl-CoA desaturase-1 expression in skeletal muscle contributes to abnormal fatty acid partitioning in obese humans. Cell Metab (2005) 3.47

Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity. Diabetes (2001) 2.56

Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus. J Clin Invest (1994) 2.51

Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism. Am J Physiol Endocrinol Metab (2007) 2.46

Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol (2013) 2.20

Lower intrinsic ADP-stimulated mitochondrial respiration underlies in vivo mitochondrial dysfunction in muscle of male type 2 diabetic patients. Diabetes (2008) 2.07

Observations on the intestinal absorption of some oligopeptides of methionine and glycine in the rat. Clin Sci (1969) 1.99

Compensatory responses to pyruvate carboxylase suppression in islet beta-cells. Preservation of glucose-stimulated insulin secretion. J Biol Chem (2006) 1.74

Circulating branched-chain amino acid concentrations are associated with obesity and future insulin resistance in children and adolescents. Pediatr Obes (2012) 1.69

Regulation of adipose branched-chain amino acid catabolism enzyme expression and cross-adipose amino acid flux in human obesity. Am J Physiol Endocrinol Metab (2013) 1.58

Acute regulation of fatty acid uptake involves the cellular redistribution of fatty acid translocase. J Biol Chem (2000) 1.52

Carbohydrate metabolism in non-insulin-dependent diabetes mellitus. N Engl J Med (1992) 1.47

Metabolic profiling of PPARalpha-/- mice reveals defects in carnitine and amino acid homeostasis that are partially reversed by oral carnitine supplementation. FASEB J (2008) 1.45

Acylcarnitine profile analysis. Genet Med (2008) 1.33

Species variation in the fecal metabolome gives insight into differential gastrointestinal function. J Proteome Res (2007) 1.30

Skeletal muscle lipid oxidation and obesity: influence of weight loss and exercise. Am J Physiol Endocrinol Metab (2008) 1.29

Metabolomic profiling reveals mitochondrial-derived lipid biomarkers that drive obesity-associated inflammation. PLoS One (2012) 1.27

Mitochondrial lipid oxidation is impaired in cultured myotubes from obese humans. Int J Obes (Lond) (2011) 1.20

Impaired fat oxidation after a single high-fat meal in insulin-sensitive nondiabetic individuals with a family history of type 2 diabetes. Diabetes (2007) 1.13

A high-fat diet elicits differential responses in genes coordinating oxidative metabolism in skeletal muscle of lean and obese individuals. J Clin Endocrinol Metab (2010) 1.09

Short-term effects of dietary fatty acids on muscle lipid composition and serum acylcarnitine profile in human subjects. Obesity (Silver Spring) (2010) 1.09

Observations of branched-chain amino acid administration in humans. J Nutr (2005) 1.03

Acylcarnitines: analysis in plasma and whole blood using tandem mass spectrometry. Methods Mol Biol (2011) 1.00

Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity. Gene (2013) 0.97

BMI, RQ, diabetes, and sex affect the relationships between amino acids and clamp measures of insulin action in humans. Diabetes (2013) 0.91

Effect of exercise training on metabolic flexibility in response to a high-fat diet in obese individuals. Am J Physiol Endocrinol Metab (2012) 0.89

PPARs and the orchestration of metabolic fuel selection. Pharmacol Res (2009) 0.89

The metabolic signature associated with the Western dietary pattern: a cross-sectional study. Nutr J (2013) 0.87

Implications of mitochondrial uncoupling in skeletal muscle in the development and treatment of obesity. FEBS J (2013) 0.84

Urinary organic acid profiles in fatty Zucker rats: indications for impaired oxidation of butyrate and hexanoate. Metabolism (1990) 0.79